MedTrace Logo

Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases

NCT07492953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-03-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether enhanced external counterpulsation (EECP) therapy can improve cardiopulmonary function and symptoms in adults with long COVID. It will also evaluate the safety and feasibility of two different EECP treatment schedules.

The main questions it aims to answer are:

* Does EECP therapy improve functional exercise capacity and cardiopulmonary performance in patients with long COVID?
* Do different EECP treatment schedules (standard vs. accelerated sessions) lead to different improvements in symptoms, quality of life, and physiological outcomes?
* What side effects or medical problems occur during EECP therapy?

Researchers will compare two EECP treatment schedules to determine whether a shorter, accelerated program provides similar benefits to the standard schedule.

Participants will:

* Receive EECP therapy either 1 hour per day (5 days per week for 7 weeks) or 2 hours per day (5 days per week for about 4 weeks), both totaling 35 hours of treatment
* Visit the cardiopulmonary rehabilitation clinic regularly for supervised treatment sessions
* Complete physical performance tests (such as the Six-Minute Walk Test and cardiopulmonary exercise testing)
* Have blood pressure and heart rate measured
* Complete questionnaires about symptoms, physical function, sleep quality, and quality of life

Conditions

  • Long COVID Symptoms

Interventions

DEVICE

enhanced external counterpulsation

Participants receive enhanced external counterpulsation (EECP) therapy achieving the same total treatment dose of 35 hours.

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-25
Primary Completion
2024-06-24
Completion
2024-06-24

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07492953 on ClinicalTrials.gov